Results 101 to 110 of about 861,721 (390)

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Cytopathology of solid pancreatic neoplasms: An algorithmic approach to diagnosis

Cancer Cytopathology, 2022
Qun Wang, Michelle D. Reid
semanticscholar   +1 more source

A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.

Archives of Pathology & Laboratory Medicine, 2019
CONTEXT.— According to the 2017 World Health Organization classification, pancreatic neuroendocrine neoplasms (PanNENs) include a new category of pancreatic neuroendocrine tumor, grade 3, which is often difficult to differentiate from pancreatic ...
Jiayun M Fang, Jiaqi Shi
semanticscholar   +1 more source

Surgical management for pancreatic neuroendocrine neoplasms with synchronous hepatic metastases: A literature review

Surgery in Practice and Science, 2022
Pancreatic neuroendocrine neoplasms (pNENs) are a group of heterogeneous neoplasms originating from pancreatic neuroendocrine cells. In recent years, with the development of diagnostic technology, the incidence has increased in the past decades.
Bohui Yin, Ruichen Gao, Qiang Xu, Xianze Wang, Wenming Wu   +4 more
doaj  

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

The FELIX Project: Deep Networks To Detect Pancreatic Neoplasms

medRxiv, 2022
Y. Xia, Q. Yu, L. Chu, S. Kawamoto, S. Park, F. Liu, J. Chen, Z. Zhu, B. Li, Z. Zhou, Y. Lu, Y. Wang, W. Shen, L. Xie, Y. Zhou, elliot k fishman, A. Javed, D. Fouladi, S. Shayesteh, J. Graves, A. Blanco, E. Zinreich, B. Kinny-Koster, K. Kinzler, R. Hruban, B. Vogelstein, A. Yuille, E. Fishman   +27 more
semanticscholar   +1 more source

Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection.

Annals of Surgery, 2019
OBJECTIVE To determine if intraoperative near-infrared (NIR) imaging carries benefit in resection of pancreatic neoplasms. BACKGROUND Resection of pancreatic malignancies is hindered by high rates of local and distant recurrence from positive margins ...
Andrew D. Newton, J. Predina, Michael H. Shin, Lydia G Frenzel-Sulyok, C. Vollmer, J. Drebin, S. Singhal, M. K. Lee   +7 more
semanticscholar   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review [PDF]

, 2019
Background: Intrapancreatic accessory spleen (IPAS) is an uncommon finding of pancreatic mass. Differential diagnosis with pancreatic tumor, especially with non-functional neuroendocrine tumor (NF-NET), may be very hard and sometimes it entails ...
Bellato, V., Caronna, R., Cerasari, S., Chirletti, P., Ciardi, A., Cicconi, S., Feola, T., Lancellotti, F., Muttillo, E. M., Sacco, L.   +9 more
core   +1 more source

Paraganglioma Mimicking a Pancreatic Neoplasm

JOP : Journal of the pancreas, 2011
Context Paragangliomas are rare tumours of neural crest origin. Extra-adrenal pancreatic paragangliomas are exceptionally rare. Case report A 66-year-old man with abdominal pain was noted to have a complex pancreatic head and uncinate process mass on imaging. He underwent complete resection by pancreaticoduodenectomy with final pathology confirming a 6
Mehrdad Nikfarjam, Peter Santos, Nicole Lightfoot   +2 more
openaire   +2 more sources